Lyrica
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Dosage, Labelling and Packaging, Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 0659071 | A. Lyrica | - Recalling Firm
- Pfizer Canada Inc.
- 17300 Trans-Canada Highway
- Kirkland
- H9J 2M5
- Quebec
- CANADA
- Marketing Authorization Holder
- Pfizer Canada Inc.
- 17300 Trans-Canada Highway
- Kirkland
- H9J 2M5
- Quebec
- CANADA
| Capsule | DIN 0226841 | 25 mg |
This recall is a result of an investigation into the possibility that bottles may contain LYRICA 150
mg Capsules.
Wholesalers and pharmacies in Canada.